PMID- 25011017 OWN - NLM STAT- MEDLINE DCOM- 20150616 LR - 20221207 IS - 1439-4286 (Electronic) IS - 0018-5043 (Linking) VI - 46 IP - 10 DP - 2014 Sep TI - Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors. PG - 685-90 LID - 10.1055/s-0034-1382078 [doi] AB - Angiopoietin-related growth factor (AGF, also known as angiopoietin-like protein 6) has been introduced as a novel hepatocyte-derived factor, which antagonizes obesity and insulin resistance in mice. However, human studies show conflicting results and are limited to a small cohort of patients. In the current study, we therefore sought to investigate AGF serum levels in a large metabolically well-characterized cohort. AGF serum concentrations were determined by commercial enzyme-linked immunosorbent assay in 697 patients of a cohort from Eastern Germany (Sorbs). Correlations of AGF serum levels with clinical and biochemical measures of glucose and lipid metabolism, as well as markers of renal function, were investigated. In nondiabetic subjects (n=627), AGF was positively correlated with markers of insulin resistance and negatively correlated with high-density lipoprotein cholesterol in univariate analyses (p<0.05). After adjustment for age, gender, and body mass index, none of these factors remained independently associated with AGF, neither in nondiabetic subjects nor in patients with type 2 diabetes mellitus (T2DM) (n=70). However, we confirmed existing data of significantly higher AGF concentrations in patients with T2DM as compared to controls in this large cohort. Circulating AGF is elevated in subjects with T2DM and related to the type of antidiabetic treatment, but is not independently associated with anthropometric parameters, indices of insulin sensitivity and secretion, or a number of other adipokines. CI - (c) Georg Thieme Verlag KG Stuttgart . New York. FAU - Ebert, T AU - Ebert T AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Kralisch, S AU - Kralisch S AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Loessner, U AU - Loessner U AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Jessnitzer, B AU - Jessnitzer B AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Stumvoll, M AU - Stumvoll M AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Fasshauer, M AU - Fasshauer M AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. FAU - Tonjes, A AU - Tonjes A AD - Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany. LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140710 PL - Germany TA - Horm Metab Res JT - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme JID - 0177722 RN - 0 (ANGPTL6 protein, human) RN - 0 (Angiopoietin-Like Protein 6) RN - 0 (Angiopoietin-like Proteins) RN - 0 (Angiopoietins) RN - 0 (Blood Glucose) RN - 0 (Cholesterol, HDL) RN - 0 (Glycated Hemoglobin A) RN - 0 (Lipoproteins, HDL) RN - 0 (hemoglobin A1c protein, human) SB - IM MH - Adult MH - Angiopoietin-Like Protein 6 MH - Angiopoietin-like Proteins MH - Angiopoietins/*blood MH - Animals MH - Blood Glucose/metabolism MH - Body Mass Index MH - Cholesterol, HDL/metabolism MH - Cohort Studies MH - Diabetes Mellitus, Type 2/*blood MH - Female MH - Germany MH - Glycated Hemoglobin/metabolism MH - Humans MH - Lipoproteins, HDL/blood MH - Male MH - Mice MH - Middle Aged EDAT- 2014/07/11 06:00 MHDA- 2015/06/17 06:00 CRDT- 2014/07/11 06:00 PHST- 2014/07/11 06:00 [entrez] PHST- 2014/07/11 06:00 [pubmed] PHST- 2015/06/17 06:00 [medline] AID - 10.1055/s-0034-1382078 [doi] PST - ppublish SO - Horm Metab Res. 2014 Sep;46(10):685-90. doi: 10.1055/s-0034-1382078. Epub 2014 Jul 10.